{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:59:18Z","timestamp":1789433958670,"version":"build-2803163510"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"GSK","award":["VEO-001082"],"award-info":[{"award-number":["VEO-001082"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adults aged \u226560 years and adults with certain chronic medical conditions are at increased risk for severe respiratory syncytial virus (RSV) disease. However, RSV vaccine uptake in the United States (US) remains low, with limited awareness of RSV among adults and potential knowledge gaps among healthcare professionals (HCPs). This study assessed US HCP knowledge, attitudes, and practices (KAP) related to RSV disease and vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional, web-based survey was administered among 700 HCPs, including primary care physicians (PCPs), specialist physicians, nurse practitioners (NPs) and physician assistants (PAs), and pharmacists, between December 2024\u2013January 2025. Survey questions assessed RSV disease- and vaccination-related KAP, with descriptive statistics calculated overall and by HCP type. Characteristics associated with RSV-related KAP were identified through multivariable logistic regression modeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 700 respondents (199 PCPs, 153 specialist physicians, 148 NPs and PAs, and 200 pharmacists), 72.3% reported being very familiar with RSV disease. However, potential knowledge gaps were identified (e.g., related to approved indications for RSV vaccines and Advisory Committee on Immunization Practices [ACIP] recommendations). HCPs commonly cited patients\u2019 refusal or hesitation (62.3%) and patients\u2019 lack of awareness of RSV (58.0%) as barriers to recommending and administering RSV vaccines. Although only 36.4% of HCPs reported that their workplace stocked RSV vaccine(s), 84.1% reported recommending RSV vaccines to eligible adult patients. However, RSV vaccination recommendations were not consistently implemented among all eligible adult patients. In multivariable modeling, characteristics that were significantly associated with RSV vaccination practices included familiarity with RSV disease, knowledge of ACIP recommendations, RSV vaccine stocking, and use of clinical decision supports, among other characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Potential knowledge- and practice-related gaps remain regarding adult RSV disease and vaccination among US HCPs. Continued efforts are needed to enhance RSV-related education among HCPs and ensure eligible patients are able to access RSV vaccination.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0353266","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:46:03Z","timestamp":1784742363000},"page":"e0353266","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["US healthcare professionals\u2019 knowledge, attitudes, and practices regarding RSV disease and vaccination in adults during the 2024\u20132025 RSV season"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5652-8961","authenticated-orcid":true,"given":"Elizabeth M.","family":"La","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyli","family":"Gallington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsion","family":"Fikre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Eltoukhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaneta","family":"Balantac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Bushnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"pone.0353266.ref001","author":"CDC"},{"issue":"5","key":"pone.0353266.ref002","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1128\/JVI.01625-07","article-title":"Viral and host factors in human respiratory syncytial virus pathogenesis","volume":"82","author":"PL Collins","year":"2008","journal-title":"J Virol"},{"issue":"1","key":"pone.0353266.ref003","doi-asserted-by":"crossref","first-page":"2432745","DOI":"10.1080\/21645515.2024.2432745","article-title":"Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged \u226560 years in the United States","volume":"20","author":"EM La","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"pone.0353266.ref004","author":"FDA","year":"2023"},{"key":"pone.0353266.ref005","author":"FDA","year":"2023"},{"key":"pone.0353266.ref006","author":"FDA","year":"2024"},{"key":"pone.0353266.ref007","author":"FDA"},{"issue":"29","key":"pone.0353266.ref008","doi-asserted-by":"crossref","first-page":"793","DOI":"10.15585\/mmwr.mm7229a4","article-title":"Use of respiratory syncytial virus vaccines in older adults: recommendations of the Advisory Committee on Immunization Practices - United States, 2023","volume":"72","author":"M Melgar","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"32","key":"pone.0353266.ref009","doi-asserted-by":"crossref","first-page":"696","DOI":"10.15585\/mmwr.mm7332e1","article-title":"Use of respiratory syncytial virus vaccines in adults aged \u226560 years: updated recommendations of the Advisory Committee on Immunization Practices - United States, 2024","volume":"73","author":"A Britton","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pone.0353266.ref010","author":"CDC"},{"issue":"4","key":"pone.0353266.ref011","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s40121-025-01119-0","article-title":"Healthcare professionals\u2019 knowledge, attitudes, and practices regarding respiratory syncytial virus disease and vaccination in adults aged 60 years and older","volume":"14","author":"EM La","year":"2025","journal-title":"Infect Dis Ther"},{"issue":"2","key":"pone.0353266.ref012","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3390\/vaccines13020159","article-title":"Knowledge and attitudes regarding respiratory syncytial virus (RSV) prevention: a systematic review","volume":"13","author":"T Gavaruzzi","year":"2025","journal-title":"Vaccines (Basel)"},{"issue":"8","key":"pone.0353266.ref013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0330763","article-title":"Physician knowledge, attitudes, and perceptions of respiratory syncytial virus in older adults: a cross-sectional survey in Germany and Italy","volume":"20","author":"A Puggina","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"pone.0353266.ref014","doi-asserted-by":"crossref","first-page":"2535755","DOI":"10.1080\/21645515.2025.2535755","article-title":"RSV vaccination uptake among adults aged 60 years and older in the United States during the 2023-2025 vaccination seasons","volume":"21","author":"EM La","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"pone.0353266.ref015","author":"CDC"},{"key":"pone.0353266.ref016","author":"CDC"},{"key":"pone.0353266.ref017","author":"MedPanel"},{"key":"pone.0353266.ref018","author":"CDC"},{"key":"pone.0353266.ref019","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40121-024-01081-3","article-title":"A narrative review of key risk factors for severe illness following SARS-CoV-2, influenza virus, and respiratory syncytial virus infection","volume":"14","author":"A Branche","year":"2025","journal-title":"Infect Dis Ther"},{"key":"pone.0353266.ref020","author":"CDC","year":"2024"},{"key":"pone.0353266.ref021","author":"CDC"},{"issue":"5","key":"pone.0353266.ref022","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.japh.2022.03.021","article-title":"Accessibility of adult immunizations in pharmacies compared to physician offices in low-income communities","volume":"62","author":"R Popovian","year":"2022","journal-title":"J Am Pharm Assoc (2003)"},{"key":"pone.0353266.ref023","author":"Medicare"},{"issue":"1","key":"pone.0353266.ref024","doi-asserted-by":"crossref","first-page":"2303796","DOI":"10.1080\/21645515.2024.2303796","article-title":"Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United States","volume":"20","author":"EM La","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"pone.0353266.ref025","doi-asserted-by":"crossref","first-page":"127057","DOI":"10.1016\/j.vaccine.2025.127057","article-title":"Pharmacy and healthcare provider offices as convenient adult vaccination settings in the US: patient experiences from a survey of recently-vaccinated adults","volume":"54","author":"EM La","year":"2025","journal-title":"Vaccine"},{"key":"pone.0353266.ref026","author":"NASPA"},{"key":"pone.0353266.ref027","author":"KFF"},{"issue":"3","key":"pone.0353266.ref028","doi-asserted-by":"crossref","DOI":"10.24926\/iip.v12i3.4141","article-title":"Pharmacists without access to the EHR: practicing with one hand tied behind our backs","volume":"12","author":"DS Craddock","year":"2021","journal-title":"Innov Pharm"},{"issue":"7","key":"pone.0353266.ref029","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/vaccines12070747","article-title":"Understanding COVID-19 vaccine hesitancy in the United States: a systematic review","volume":"12","author":"G Nwachukwu","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"pone.0353266.ref030","first-page":"1","article-title":"RSV disease and vaccination knowledge, attitudes, and practices among US adults: a 2024\u20132025 RSV season survey","volume":"42","author":"EM La","year":"2026","journal-title":"Current Medical Research and Opinion"},{"key":"pone.0353266.ref031","doi-asserted-by":"crossref","first-page":"100569","DOI":"10.1016\/j.puhip.2024.100569","article-title":"Addressing vaccine hesitancy in the training of healthcare professionals: insights from the VAX-TRUST project","volume":"9","author":"FR Augusto","year":"2025","journal-title":"Public Health Pract (Oxf)"},{"issue":"1","key":"pone.0353266.ref032","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.vaccine.2022.09.093","article-title":"Vaccine hesitancy educational tools for healthcare providers and trainees: a scoping review","volume":"41","author":"A Lip","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"pone.0353266.ref033","doi-asserted-by":"crossref","first-page":"2173914","DOI":"10.1080\/21645515.2023.2173914","article-title":"Vaccine knowledge, attitudes, and recommendation practices among health care providers in New York State","volume":"19","author":"A Fernandes","year":"2023","journal-title":"Hum Vaccin Immunother"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0353266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:46:07Z","timestamp":1784742367000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0353266"}},"subtitle":[],"editor":[{"given":"Masfique","family":"Mehedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0353266","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}